Stockholders’ Deficiency

9 Months Ended

Sep. 30, 2026

Equity [Abstract]

Stockholders’ Deficiency

Stockholders’ Deficiency

Common Stock

The Company has the authority to issue 1,000,000,000 shares of common stock, $0.01 par value per share.

Restricted Stock Units – The Company issued, in connection with the vesting of restricted stock units, 0 and 13,695 shares of the Company’s common stock during the three months ended September 30, 2026 and 2025, respectively, as reflected on the condensed consolidated statements of stockholders’ deficiency. The Company issued, in connection with the vesting of restricted stock units, 15,723 and 26,193 shares of the Company’s common stock during the nine months ended September 30, 2026 and 2025, respectively, as reflected on the condensed consolidated statements of stockholders’ deficiency.

Common Stock Withheld – The Company recorded the repurchase of 0 shares related to vested restricted common stock for the payment for taxes of $0 during the three months ended September 30, 2026, and the repurchase of 2,026 shares related to vested restricted common stock for the payment for taxes of $12 during the three months ended September 30, 2025, as reflected on the condensed consolidated statements of stockholders’ deficiency.